Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MAPROTILINE vs MEBENDAZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MAPROTILINE vs MEBENDAZOLE: Safety Overview

Metric MAPROTILINE MEBENDAZOLE
Total FAERS Reports 209 440
Deaths Reported 30 28
Death Rate 14.4% 6.4%
Hospitalizations 119 70
Average Patient Age 58.2 yrs 29.5 yrs
% Female Patients 79.8% 68.4%
FDA Approval Date Approved Prior to Jan 1, 1982 Approved Prior to Jan 1, 1982
Manufacturer N/A Janssen Pharmaceuticals, Inc.
Route N/A ORAL
Marketing Status Discontinued Discontinued